Schenkein David P

Denali Therapeutics Inc. · Director

Schenkein David P is listed in public filings as director. This Schenkein David P insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Denali Therapeutics Inc. (DNLI), Regeneron Pharmaceuticals Inc (REGN), and Prime Medicine, Inc. (PRME). Investors use Schenkein David P's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Denali Therapeutics Inc.DNLI$378k19.2k sharesGrant / ExerciseJun 3, 2026$378.0K19.2k shares$19.66--
Denali Therapeutics Inc.DNLI--21.7k sharesGrant / ExerciseJun 3, 2026Disclosure amount unavailable6.4k shares----

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Regeneron Pharmaceuticals IncREGN$1.5M2k sharesGrant / ExerciseJan 2, 2026$1.5M2k shares$772.76--
Regeneron Pharmaceuticals IncREGN--603 sharesGrant / ExerciseJan 2, 2026Disclosure amount unavailable155 shares----
Prime Medicine, Inc.PRME$039.1k sharesOtherAug 1, 2025$579.3K39.1k shares$14.83--
Prime Medicine, Inc.PRME$045k sharesOtherAug 1, 2025$345.6K45k shares$7.68--
Prime Medicine, Inc.PRME$182k45k sharesGrant / ExerciseAug 1, 2025$181.8K45k shares$4.04--
Prime Medicine, Inc.PRME$158k39.1k sharesGrant / ExerciseAug 1, 2025$157.8K39.1k shares$4.04--
Prime Medicine, Inc.PRME$73k55k sharesGrant / ExerciseJun 4, 2025$72.6K55k shares$1.32--
Denali Therapeutics Inc.DNLI$252k18.1k sharesGrant / ExerciseJun 3, 2025$252.3K18.1k shares$13.93--
Denali Therapeutics Inc.DNLI--15.3k sharesGrant / ExerciseJun 3, 2025Disclosure amount unavailable6k shares----
Regeneron Pharmaceuticals IncREGN$1.4M2k sharesGrant / ExerciseJan 2, 2025$1.4M2k shares$719.37--
Regeneron Pharmaceuticals IncREGN--448 sharesGrant / ExerciseJan 2, 2025Disclosure amount unavailable166 shares----
Denali Therapeutics Inc.DNLI$303k9.2k sharesSellNov 11, 2024$1.1M32.3k shares$32.87--
Denali Therapeutics Inc.DNLI$1.3M41.5k sharesSellNov 11, 2024$870.6K27.1k shares$32.09--
Denali Therapeutics Inc.DNLI$047.2k sharesGrant / ExerciseNov 11, 2024$849.0K47.2k shares$18.00--
Prime Medicine, Inc.PRME$346k45k sharesGrant / ExerciseJun 12, 2024$345.6K45k shares$7.68--